29
Sep
2020
17:30
BST
Webinar
Emerging Clinical Evidence on Left Atrial Appendage Closure: A Case-based Discussion
-
Views:
20
-
Likes:
0
Overview
LAA closure (LAAC) is a proven alternative to oral anticoagulation for preventing stroke in patients with non-valvular AF. In the era of NOACs the clinical evidence is also emerging. Join the panelists to discuss the implications of current and future trials on clinical practice. A live case from the University Clinic Aarhus, Denmark will focus on intracardiac echocardiography (ICE) to guide the LAA closure procedure with the next generation device WATCHMAN FLX.
Faculty:
Ignacio Cruz
Jens Erik Nielsen-Kudsk
Prof Henning Ebelt
Prof Marek Grygier
Prof Tim Betts
Caroline Kleinecke
This webinar is supported by
Learning Objectives
- Discuss the emerging evidence for the LAA closure therapy in the era of NOACs
- Follow a live case with WATCHMAN FLX guided by ICE imaging
- Learn how new workstreams with ICE can reduce the need for General Anaesthesia
- Understand the benefits of combined procedures (AF Ablation + LAA closure) for patients
- Learn about the trial design and endpoints of the OPTION trial and discuss the implication on clinical practice.
- Understand how the new implantation technique of WATCHMAN FLX can optimize procedural results
Audience
- Interventional Cardiologists and Electrophysiologists who would like to learn more about the growing evidence for the LAA closure therapy with WATCHMAN FLX
- Non-invasive Cardiologists with an interest in the clinical evidence and the implications for the LAA closure therapy
Faculty Biographies
Ignacio Cruz
Prof Cruz is a Professor of Medicine at the University of Salamanca, Chief of Interventional Cardiology and Elected President of the Spanish Society of Interventional Cardiology. He is a leading and pioneering interventional cardiologist and the main driver behind the Salamanca-based interventional cardiology meetings. He is also highly involved in the research for structural intervention solutions. He is a true pioneer in the field of paravalvular leak closure and the driving force behind the HOLE-registry with 500 reported PVL cases.
Prof Tim Betts
John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, UK
Key References
1. OPTION
https://www.bostonscientific.com/en-US/products/laac-system/option-clinical-trial.html
https://clinicaltrials.gov/ct2/show/NCT03795298
2. ICE-LAA
https://clinicaltrials.gov/ct2/show/NCT04196335
3. ASAP TOO
https://www.bostonscientific.com/en-US/products/laac-system/asap-too.html
https://clinicaltrials.gov/ct2/show/NCT02928497